# Primary Breast Cancer Occurring Concomitant With Pregnancy

> **NCT00510367** · EARLY_PHASE1 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 61 (actual)

## Conditions studied

- Breast Cancer
- Pregnancy

## Interventions

- **DRUG:** 5-Fluorouracil
- **DRUG:** Cyclophosphamide
- **DRUG:** Doxorubicin

## Key facts

- **NCT ID:** NCT00510367
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-08-07
- **Primary completion:** 2020-07-08
- **Final completion:** 2020-07-08
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2020-07-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00510367

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00510367, "Primary Breast Cancer Occurring Concomitant With Pregnancy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00510367. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*